Skip to main content
NewslettersWatchlist
hello world

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Stocks in play: MediPharm Labs Corp.

Baystreet.ca - Baystreet - Thu Aug 1, 8:52AM CDT

Announced it has entered into a licencing agreement with Remidose Aerosols Inc. to acquire the exclusive rights for advanced cannabis products. MediPharm Labs Corp. shares T.LABS are trading unchanged at $0.07.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).